Stay away from both for now, even after the crashes. There are plenty of better biotech-pharma out there that are oversold and have better risk/reward which you can better apply your funds into.
I'm reviewing many right now (and as always) that don't have this type of risk.
I would've told you in the past not to buy MSTX in recent days-weeks after the crash, and would've saved you money. Just take your medicine--- learn from it & exit. I'll hook you up with some alternatives in near future or if you contact me privately.
I only tried PVCT that one time and it was one anomaly where I broke some of my screening criteria rules (and it won't happen again)
A couple weeks ago I simply tried PVCT because the candle stick chart looked like it was primed to reverse upward a little while, but I broke other criteria rules (that I personally developed over many years) which PVCT didn't qualify on, and I broke my rules, and the result since then is evident of the necessity that my screening criteria system has to be followed with no expectations.
Doing so made my first loss since May 2016 (but for only -5%)
News 
Market Data 
Discover 
